Results 191 to 200 of about 41,965 (298)

Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. [PDF]

Psychopharmacology (Berl), 2018
Maggio SE, Saunders MA, Baxter TA, Nixon K, Prendergast MA, Zheng G, Crooks P, Dwoskin LP, Slack RD, Newman AH, Bell RL, Bardo MT.   +11 more
europepmc   +1 more source

Agonist-Specific Pharmacological Effects of CMPI and NS9283 at (α4)3(β2)2 Neuronal Nicotinic. Acetylcholine Receptors [PDF]

, 2018
Kemburli Munoz, Farah Deba, Ayman K. Hamouda   +2 more
openalex   +1 more source

Use of Psychoactive Substances Before Incarceration Among Prison Inmates With Drug Abuse or Dependence: Data From the OPPIDUM Program

Fundamental &Clinical Pharmacology, Volume 40, Issue 1, January 2026.
ABSTRACT Background The objective of this study was to assess the prevalence of dependence and abuse of psychoactive substances (PAS) among prison inmates, using data from the OPPIDUM program between 2013 and 2022. Methods OPPIDUM is an annual, cross‐sectional national program, conducted among users consulting in specialised addiction centres.
Zeinab Abbas, Clémence Lacroix, Elisabeth Jouve, Céline Eiden, Joelle Micallef, Hélène Peyrière, and the French Addictovigilance network, Alexandre Peyre, Reynald Leboisselier, Celian Bertin, Nathalie Fouilhe, Anne‐Sylvie Caous, Johan Thiery, Marylène Guerlais, Lauriane Charuel, Stéphanie Pain, Emilie Jouanjus   +16 more
wiley   +1 more source

Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective. [PDF]

Int J Mol Sci, 2015
Neumann S, Shields NJ, Balle T, Chebib M, Clarkson AN.   +4 more
europepmc   +1 more source

P4–310: Preclinical characterization of a selective alpha‐7 neuronal nicotinic acetylcholine receptor agonist ABT‐126: A novel therapeutic agent for the treatment of cognitive impairment in Alzheimer's disease and schizophrenia [PDF]

, 2013
Robert S. Bitner, David J. Anderson, Karla Drescher, Kathy L. Kohlhaas, Halvard Gronlien, Min Hu, Jinhe Li, Stella Markosyan, Kennan Marsh, Eric G. Mohler, Arthur L. Nikkel, Richard J. Radek, Holly M. Robb, Michael R. Schrimpf, Jeffrey F. Waring, Chih‐Hung Lee, Murali Gopalakrishnan   +16 more
openalex   +1 more source

Differential Immediate and Sustained Memory Enhancing Effects of Alpha7 Nicotinic Receptor Agonists and Allosteric Modulators in Rats

, 2011
Morten S. Thomsen, Mona El-Sayed, Jens D. Mikkelsen   +2 more
openalex   +2 more sources

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes

Journal of the American Geriatrics Society, Volume 74, Issue 1, Page 96-106, January 2026.
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen, Yu‐Wei Fang, Ya‐Fang Liu, Mon‐Ting Chen, Ming‐Hsien Tsai   +4 more
wiley   +1 more source

Neuroprotective effects of a nicotinic acetylcholine receptor agonist and modulator in the rodent retina

, 2011
Kazuhiro Iwamoto
openalex   +1 more source

Discovery of 4-(5-Methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models

, 2009
Christopher J. O’Donnell, Bruce N. Rogers, Brian S. Bronk, Dianne K. Bryce, Jotham W. Coe, Karen K. Cook, Allen J. Duplantier, Edelweiss Evrard, Mihály Hajós, William E. Hoffmann, Raymond S Hurst, Noha Maklad, Robert J. Mather, Stafford McLean, Frank M. Nedza, Brian T. O’Neill, Langu Peng, Weimin Qian, Melinda M. Rottas, Steven B. Sands, Anne W. Schmidt, Alka Shrikhande, Douglas K. Spracklin, Diane Wong, Andy Zhang, Lei Zhang   +25 more
openalex   +1 more source

The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain [PDF]

, 2016
Deniz Bağdaş, Jenny L. Wilkerson, Abhijit Kulkarni, Wisam Toma, Shakir D. AlSharari, Zülfiye Gül, Aron H. Lichtman, Roger L. Papke, Ganesh A. Thakur, M. Imad Damaj   +9 more
openalex   +1 more source